Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Miraca Holdings Inc

+ Add to Watchlist

4544:JP

5,990.0 JPY 50.0 0.83%

As of 02:00:00 ET on 04/24/2015.

Snapshot for Miraca Holdings Inc (4544)

Open: 5,990.0 Day's Range: 5,930.0 - 6,010.0 Volume: 144,600
Previous Close: 6,040.0 52wk Range: 4,125.0 - 6,160.0 1-Yr Rtn: +36.75%

Stock Chart for 4544

No chart data available.
  • 4544:JP 5,990.0
  • 1D
  • 1M
  • 1Y
6,040.0
Interactive 4544 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4544

Current P/E Ratio (ttm) 21.3562
Estimated P/E(03/2015) 21.7771
Relative P/E vs. TPX 1.1568
Earnings Per Share (JPY) (ttm) 280.4800
Est. EPS (JPY) (03/2015) 275.0590
Est. PEG Ratio 3.2503
Market Cap (M JPY) 342,256.42
Shares Outstanding (M) 57.14
30 Day Average Volume 229,143
Price/Book (mrq) 1.9561
Price/Sale (ttm) 1.7150
Dividend Indicated Gross Yield 1.54%
Cash Dividend (JPY) 46.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 8.92%
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4544

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4544

Miraca Holdings Inc. develops, manufactures, exports, and imports clinical reagents, medical drugs, and medical equipment. The Company's clinical reagents are for cancer, malignant tumor, hypothyroidism, diabetes, and infectious diseases including AIDS. Miraca Holdings also conducts clinical tests for hospitals and medical organizations.

Hiromasa SuzukiPresidentShinji OgawaSenior Executive Officer
Hiromitsu TazawaSenior Executive OfficerTakeshi KoyamaManaging Executive Officer
More Company Profile & Key Executives for 4544

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil